We at CFIF have steadfastly highlighted the consumer benefits of the proposed T-Mobile/Sprint merger…
CFIF on Twitter CFIF on YouTube
WSJ Urges Regulators to Approve T-Mobile/Sprint Merger

We at CFIF have steadfastly highlighted the consumer benefits of the proposed T-Mobile/Sprint merger, and cautioned the federal government against any pointless and destructive objection to the deal.  In today's Wall Street Journal, its editorial board encourages the Department of Justice (DOJ) to move forward on the deal:

The Justice Department lost its lawsuit to block AT&T's purchase of Time Warner.  Yet now the antitrust cops are holding up T-Mobile's merger with Sprint even though it could give AT&T more competition in wireless.  What gives?

A year ago, T-Mobile announced plans to acquire Sprint for $26 billion in stock, yet the merger is still stuck in government antitrust purgatory.  The Federal Communications Commission keeps pausing its 180-day shot clock on the merger…[more]

April 22, 2019 • 04:07 pm

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Jester's CourtroomLegal tales stranger than stranger than fiction: Ridiculous and sometimes funny lawsuits plaguing our courts.
Home Press Room CFIF Urges Opposition to S. 977, Legislation to Import Foreign Price Controls
CFIF Urges Opposition to S. 977, Legislation to Import Foreign Price Controls Print
Thursday, April 04 2019

ALEXANDRIA, VA — In November of last year, the Center for Individual Freedom (“CFIF”) joined with 57 free-market organizations and individuals on a coalition letter opposing the importation of foreign price controls on prescription drugs, a proposal currently under consideration at the U.S. Department of Health and Human Services ("HHS").  In a coalition video released last week, several leading free-market voices, including CFIF, spoke out once again against the perils of imposing foreign price controls.

Unfortunately, recently introduced legislation by Senator Rick Scott (R-FL) entirely ignores that overwhelming opposition from conservatives and the free-market community and seeks to import foreign price controls into the U.S.  This legislation, known as the “Transparent Drug Pricing Act” (S.977), would fix U.S. drug prices to the lowest cost of the same drugs sold in five other countries: Canada, France, the United Kingdom, Japan and Germany.

It is CFIF's strong belief that importing socialist price controls in an effort to lower drug prices is the wrong approach and will reduce access to medicines, kill innovation and harm patients.  Therefore, CFIF urges Senators not to cosponsor or vote in favor of this harmful legislation.

###

 

 

Question of the Week   
In which one of the following years was the first White House Easter Egg Roll held?
More Questions
Quote of the Day   
 
"The credibility of the Democratic Party is now at issue.If Mueller could not find collusion, what reason is there to believe Rep. Jerry Nadler's judiciary committee will find it, and then convince the country that they have discovered what ex-FBI Director Mueller could not.With conspiracy and collusion off the table, and Mueller saying the case for obstruction is unproven, the renewed attack on Trump…[more]
 
 
—Patrick J. Buchanan, Syndicated Columnist and The American Conservative Magazine Founding Editor
— Patrick J. Buchanan, Syndicated Columnist and The American Conservative Magazine Founding Editor
 
Liberty Poll   

How likely are you to read all or a significant part of the Mueller Report?